Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Bonnin, Nathalie
355  Ergebnisse:
Personensuche X
?
1

A PK-PD model linking biomarker dynamics to progression-fre..:

Puszkiel, Alicja ; You, Benoit ; Payen, Léa...
Cancer Chemotherapy and Pharmacology.  91 (2023)  5 - p. 413-425 , 2023
Link: https://doi.org/10.1007/..
 
?
2

Clinical results of the EVESOR trial, a multiparameter phas..:

Varnier, Romain ; Puszkiel, Alicja ; Tod, Michel...
Cancer Chemotherapy and Pharmacology.  91 (2023)  5 - p. 361-373 , 2023
Link: https://doi.org/10.1007/..
 
?
3

Optimization of G-CSF dosing schedule in patients treated w..:

Reda, Manon ; Macaire, Pauline ; Bellio, Hélène...
Cancer Chemotherapy and Pharmacology.  89 (2022)  2 - p. 197-208 , 2022
Link: https://doi.org/10.1007/..
 
?
4

Geriatric oncologists should be aware of cardio-oncology: I..:

Valero, Marie ; Courand, Pierre-Yves ; Gilbert, Thomas...
Journal of Geriatric Oncology.  11 (2020)  8 - p. 1337-1339 , 2020
Link: https://doi.org/10.1016/..
 
?
5

Actionable molecular alterations in advanced gynaecologic m..:

Varnier, Romain ; Le Saux, Olivia ; Chabaud, Sylvie...
European Journal of Cancer.  118 (2019)  - p. 156-165 , 2019
Link: https://doi.org/10.1016/..
 
?
6

MiR-422a promotes loco-regional recurrence by targeting NT5..:

Bonnin, Nathalie ; Armandy, Emma ; Carras, Julien...
Oncotarget.  7 (2016)  28 - p. 44023-44038 , 2016
Link: https://doi.org/10.18632..
 
?
7

Predicting everolimus treatment efficacy in patients with a..:

Trédan, Olivier ; Treilleux, Isabelle ; Wang, Qing...
Targeted Oncology.  8 (2012)  4 - p. 243-251 , 2012
Link: https://doi.org/10.1007/..
 
?
8

COMICS TRIP:

, In: ACM SIGGRAPH 2001 video review on Animation theater program,
BARNOUIN, Christophe ; BONNIN, Nathalie ; DESGARDIN, Luc. - p. 6 ff. , 2001
Link: https://dl.acm.org/doi/1..
 
?
9

Actionable molecular alterations in advanced gynaecologic m..:

Varnier, Romain ; Le Saux, Olivia ; Chabaud, Sylvie...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ejca.2019.06.017.  , 2019
Link: https://hal.science/hal-..
 
?
10

Actionable molecular alterations in advanced gynaecologic m..:

Varnier, Romain ; Le Saux, Olivia ; Chabaud, Sylvie...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ejca.2019.06.017.  , 2019
Link: https://hal.science/hal-..
 
?
11

Actionable molecular alterations in advanced gynaecologic m..:

Varnier, Romain ; Le Saux, Olivia ; Chabaud, Sylvie...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ejca.2019.06.017.  , 2019
Link: https://hal.science/hal-..
 
?
12

Actionable molecular alterations in advanced gynaecologic m..:

Varnier, Romain ; Le Saux, Olivia ; Chabaud, Sylvie...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ejca.2019.06.017.  , 2019
Link: https://hal.science/hal-..
 
?
13

Actionable molecular alterations in advanced gynaecologic m..:

Varnier, Romain ; Le Saux, Olivia ; Chabaud, Sylvie...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ejca.2019.06.017.  , 2019
Link: https://hal.archives-ouv..
 
?
14

MiR-422a promotes loco-regional recurrence by targeting NT5..:

Bonnin, Nathalie ; Armandy, Emma ; Carras, Julien...
info:eu-repo/semantics/altIdentifier/doi/10.18632/oncotarget.9829.  , 2016
Link: https://hal.science/hal-..
 
?
15

MiR-422a promotes loco-regional recurrence by targeting NT5..:

Bonnin, Nathalie ; Armandy, Emma ; Carras, Julien...
info:eu-repo/semantics/altIdentifier/doi/10.18632/oncotarget.9829.  , 2016
Link: https://hal.science/hal-..
 
1-15